ReviR, Kennedy`s Disease Association Partner on Rare Neuro Disorder
25 Nov 2024 //
PR NEWSWIRE
ReviR Therapeutics Secures $30M For CNS Disorder Genetic Medicines
26 Jul 2024 //
PR NEWSWIRE
CMT partners with ReviR Research to advance small molecule therapeutics
21 Jun 2024 //
PHARMABIZ
ReviR Reaches Milestone In Splicing Therapy Development With Asieris
17 Jun 2024 //
PR NEWSWIRE